Evidence map›Paper›PMID 42039358›Full record

ReviewFrontiers in cardiovascular medicine2026

Calcium modifying dedicated balloons: a contemporary review.

Giuseppe Colletti, Zoltan Ruzsa, Olivier Gach, Adrien Jossart, Laura Peter, Agostino Spanò, Nino Cocco, Marouane Boukhris, Claudiu Ungureanu

Abstract readReview
In one paragraph

Review in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Giuseppe Colletti *Department of Cardiology, Clinique St. Joseph-Groupe Vivalia, Arlon, Belgium.
Zoltan Ruzsa *Internal Medicine Department, Cardiology Center, University of Szeged, Szeged, Hungary.
Olivier GachDepartment of Cardiology, CHC MontLégia, Liège, Belgium.
Adrien JossartDepartment of Cardiology, Jolimont Hospital-CHU Helora, La Louvière, Belgium.
Laura PeterDepartment of Cardiology, Clinique St. Joseph-Groupe Vivalia, Arlon, Belgium.
Agostino SpanòDepartment of Cardiovascular Sciences, Campus Bio-medico University Hospital, Rome, Italy.
Nino CoccoDepartment of Cardiovascular Sciences, Campus Bio-medico University Hospital, Rome, Italy.
Marouane BoukhrisDepartment of Cardiology, CHU Saint Etienne, Saint-Étienne, France.
Claudiu UngureanuDepartment of Cardiovascular Sciences, Campus Bio-medico University Hospital, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Calcified coronary lesions are a major challenge in percutaneous coronary intervention (PCI), frequently leading to stent underexpansion, restenosis, and adverse events. While multiple technologies exist for plaque modification, there remains a critical need for clear guidance on the optimal selection and use of dedicated balloon-based devices. Summary: This review summarizes current evidence on scoring balloons, cutting balloons, and ultra-high-pressure (OPN NC) balloons and aims to define their specific role and indications in the treatment of calcified coronary disease. Particular attention is given to how lesion morphology, calcium characteristics, and procedural context influence device selection. Scoring balloons use external nitinol elements to create controlled focal stress, particularly effective in eccentric calcium. Cutting balloons incorporate microblades mounted on the balloon surface, allowing intimal incisions and fracture of concentric and mixed calcification or fibrotic tissue; repeated sequential inflations, as proposed in the RODIN-CUT technique, may enhance calcium disruption in a dose-dependent manner. OPN NC balloons, capable of inflations up to 35-40 atm, provide an effective last-resort option in undilatable lesions. Across devices, intravascular imaging plays a pivotal role in characterizing calcium morphology, guiding device selection and sizing, and confirming plaque modification. Conclusions: Calcium-modifying balloons provide predictable and versatile strategies for treating calcified coronary disease suitable both as a first-line option and as a complementary tool alongside intravascular lithotripsy or atherectomy. Device performance is tightly linked to lesion selection, procedural technique, and intravascular imaging guidance. An individualized, integrated, and morphology-tailored multimodality approach remains the most pragmatic strategy.

Indexed as

calcified coronary lesioncoronary artery diseasecutting balloonintravascular imagingOPN NC balloonpercutaneous coronary interventionscoring balloon

Identifiers

PMID42039358
PMCPMC13106395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.